Cost Effectiveness of Sunitinib Versus Pazopanib and Best Supportive Care for the Treatment of Metastatic Renal Cell Carcinoma in Chile
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2227
https://www.valueinhealthjournal.com/article/S1098-3015(16)33593-8/fulltext
Title :
Cost Effectiveness of Sunitinib Versus Pazopanib and Best Supportive Care for the Treatment of Metastatic Renal Cell Carcinoma in Chile
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33593-8&doi=10.1016/j.jval.2016.09.2227
First page :
A736
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2116